Functional analysis of SHARPIN and PRMT5 in clear cell sarcoma
Project/Area Number |
18K16639
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 56020:Orthopedics-related
|
Research Institution | Osaka International Cancer Institute |
Principal Investigator |
Tamiya Hironari 地方独立行政法人大阪府立病院機構大阪国際がんセンター(研究所), その他部局等, リハビリテーション科 部長 (70811686)
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2020: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Keywords | 悪性骨軟部腫瘍 / フェロトーシス / SHARPIN / 悪性軟部腫瘍 / 淡明細胞肉腫 / PRMT5 |
Outline of Final Research Achievements |
TCGA dataset of soft tissue sarcoma 265 cases showed that high SHARPIN expression is associated with poor prognosis. SHARPIN inhibition enhanced resistance against ferroptosis. Further investigation will be warranted to clarify the sensitivity of ferroptosis on sarcoma entities with high SHARPIN expression which is correlated with poor prognosis.
|
Academic Significance and Societal Importance of the Research Achievements |
悪性骨軟部腫瘍(肉腫)は難治性希少がんであり有効な化学療法が少なく新たな治療薬の開発が強く望まれている。本研究にてSHARPINと予後不良との関連および鉄依存性細胞死フェロトーシスへの関与を解明できた。本研究を礎にして、今後肉腫における新規抗がん剤治療としてフェロトーシスの有効性を明らかにし肉腫患者の予後を改善させるため臨床応用を目指したい。
|
Report
(4 results)
Research Products
(26 results)
-
-
-
-
-
-
-
-
-
[Journal Article] Survival analysis of elderly patients with osteosarcoma2019
Author(s)
Imura Yoshinori、Takenaka Satoshi、Kakunaga Shigeki、Nakai Takaaki、Wakamatsu Toru、Outani Hidetatsu、Tanaka Takaaki、Tamiya Hironari、Oshima Kazuya、Hamada Kenichiro、Naka Norifumi、Araki Nobuhito、Kudawara Ikuo、Ueda Takafumi、Yoshikawa Hideki
-
Journal Title
International Orthopaedics
Volume: 43
Issue: 7
Pages: 1741-1747
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-